SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern

The continuous transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has required that diagnostic capabilities be constantly monitored and updated as new variants emerge and prior variants disappear. Although whole genome sequencing provides full characterisation...

Full description

Bibliographic Details
Main Authors: Kym Lowry, Claire Wang, Amanda Bordin, Cameron Buckley, Steven Badman, Patrick Harris, Ian Mackay, David Whiley
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/9/2056
_version_ 1797489565021241344
author Kym Lowry
Claire Wang
Amanda Bordin
Cameron Buckley
Steven Badman
Patrick Harris
Ian Mackay
David Whiley
author_facet Kym Lowry
Claire Wang
Amanda Bordin
Cameron Buckley
Steven Badman
Patrick Harris
Ian Mackay
David Whiley
author_sort Kym Lowry
collection DOAJ
description The continuous transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has required that diagnostic capabilities be constantly monitored and updated as new variants emerge and prior variants disappear. Although whole genome sequencing provides full characterisation of SARS-CoV-2 directly from patient samples, this has limited throughput and requires sufficient resources. To enhance screening for circulating variants, we designed a rapid in-house RT-PCR assay to target a spike mutation (D950N) in Delta variants, which is not detected in the remaining variants of concern (VOCs). Assay sensitivity for detecting Delta variants was 93% and specificity was 100% using a sequenced sample bank of several lineages. As the D950N mutation is prevalent in >95% of the global Delta variant sequences deposited in GISAID, this assay has the potential to provide rapid results to determine if the samples are presumptively Delta variants and can support clinicians in timely clinical decision-making for effective treatments and surveillance.
first_indexed 2024-03-10T00:18:25Z
format Article
id doaj.art-ed5b77db26624145ae9abfea8c52e35f
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T00:18:25Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-ed5b77db26624145ae9abfea8c52e35f2023-11-23T15:48:00ZengMDPI AGDiagnostics2075-44182022-08-01129205610.3390/diagnostics12092056SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of ConcernKym Lowry0Claire Wang1Amanda Bordin2Cameron Buckley3Steven Badman4Patrick Harris5Ian Mackay6David Whiley7The Queensland Paediatric Infectious Diseases (QPID) Research Group, Queensland Children’s Hospital, Brisbane, QLD 4101, AustraliaThe Queensland Paediatric Infectious Diseases (QPID) Research Group, Queensland Children’s Hospital, Brisbane, QLD 4101, AustraliaThe Queensland Paediatric Infectious Diseases (QPID) Research Group, Queensland Children’s Hospital, Brisbane, QLD 4101, AustraliaInfectious Diseases Laboratory, Prevention Division, Pathology Queensland, Brisbane, QLD 4006, AustraliaKirby Institute for Infection and Immunity in Society, University of New South Wales (UNSW) Medicine, UNSW Sydney, Kensington, Sydney, NSW 2052, AustraliaThe University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, AustraliaInfectious Diseases Laboratory, Prevention Division, Pathology Queensland, Brisbane, QLD 4006, AustraliaThe Queensland Paediatric Infectious Diseases (QPID) Research Group, Queensland Children’s Hospital, Brisbane, QLD 4101, AustraliaThe continuous transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has required that diagnostic capabilities be constantly monitored and updated as new variants emerge and prior variants disappear. Although whole genome sequencing provides full characterisation of SARS-CoV-2 directly from patient samples, this has limited throughput and requires sufficient resources. To enhance screening for circulating variants, we designed a rapid in-house RT-PCR assay to target a spike mutation (D950N) in Delta variants, which is not detected in the remaining variants of concern (VOCs). Assay sensitivity for detecting Delta variants was 93% and specificity was 100% using a sequenced sample bank of several lineages. As the D950N mutation is prevalent in >95% of the global Delta variant sequences deposited in GISAID, this assay has the potential to provide rapid results to determine if the samples are presumptively Delta variants and can support clinicians in timely clinical decision-making for effective treatments and surveillance.https://www.mdpi.com/2075-4418/12/9/2056SARS-CoV-2RT-PCRvariant assayvariant of concernDeltawhole genome sequencing
spellingShingle Kym Lowry
Claire Wang
Amanda Bordin
Cameron Buckley
Steven Badman
Patrick Harris
Ian Mackay
David Whiley
SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
Diagnostics
SARS-CoV-2
RT-PCR
variant assay
variant of concern
Delta
whole genome sequencing
title SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
title_full SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
title_fullStr SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
title_full_unstemmed SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
title_short SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
title_sort sars cov 2 rt pcr to screen for b 1 617 2 delta variant of concern
topic SARS-CoV-2
RT-PCR
variant assay
variant of concern
Delta
whole genome sequencing
url https://www.mdpi.com/2075-4418/12/9/2056
work_keys_str_mv AT kymlowry sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT clairewang sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT amandabordin sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT cameronbuckley sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT stevenbadman sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT patrickharris sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT ianmackay sarscov2rtpcrtoscreenforb16172deltavariantofconcern
AT davidwhiley sarscov2rtpcrtoscreenforb16172deltavariantofconcern